Jim Keon
politicianMale0.0Global Dominance: 0.00%
Jim Keon is the president of the Canadian Generic Pharmaceutical Association (CGPA), representing 17 companies in the generics industry. He has been vocal about the delays in Health Canada's approval process for generic drugs, highlighting the impact these delays have on both patients and the financial burden on public and private insurers.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jim Keon, president of industry group Biosimilars Canada, said the delays are threatening the financial viability of these products.
Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissionsThe Globe and Mail·
Canada· 2025-09-05
Canada· 2025-09-05
Jim Keon, president of the CGPA, highlighted the resource shortages and increased submission volume affecting Health Canada's drug approval process.
Health Canada taking longer to approve generic drugs, data showThe Globe and Mail·Canada· 2025-08-05
Canada· 2025-08-05
